This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Incyte Holdings Comoration. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Chester, PA (US) (2019 - 2020)
- San Jose, CA (US) (2022 - 2024)
Company Filing History:
6 out of 687 
5 out of 151 
1 out of 1 Years Active: 2019-2024
Title: Susan Erickson-Viitanen: Innovator in Sustained-Release Formulations
Introduction
Susan Erickson-Viitanen is a prominent inventor based in West Chester, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release dosage forms. With a total of six patents to her name, her work has had a substantial impact on the treatment of various diseases.
Latest Patents
One of her latest patents focuses on sustained-release dosage forms of ruxolitinib. This invention relates to formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders. This innovative approach aims to improve the efficacy and patient compliance in the treatment of these conditions.
Career Highlights
Throughout her career, Susan has worked with notable companies, including Incyte Corporation and Incyte Holdings Corporation. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical formulations and contribute to groundbreaking research.
Collaborations
Susan has collaborated with talented individuals in her field, including Yong Ni and Bhavnish Parikh. These partnerships have fostered innovation and have been instrumental in advancing her research and development efforts.
Conclusion
Susan Erickson-Viitanen is a distinguished inventor whose work in sustained-release formulations has made a significant impact in the pharmaceutical industry. Her contributions continue to influence the treatment of important medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile